The weekly litigation news digest is live. Subscribe now

IP Verse

Nuvamid competitive analysis

Loading summary...

Latest patents of Nuvamid opposed by its competitors

Explore Nuvamid's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP4084799
Apr 17, 2024Use Of Nmn For The Prevention And/Or Treatment Of Joint Pain Induced By Physical Activity, And Corresponding Compositions1
EP4196127
Jan 31, 2024Nicotinamide Mononucleotide Derivatives And Use Thereof In The Treatment And Prevention Of A Red Blood Cell Disorder1
EP4028021
Jan 24, 2024Use Of Nmn For The Prevention And/Or Treatment Of Pain, And Corresponding Compositions1

Latest PTAB cases involving Nuvamid

Discover the latest PTAB cases involving Nuvamid, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Nuvamid with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
NUVAMID - 3 - -
SCHLICH32 - - -